Envista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024. In the quarter to June 2026, revenue grew 7.10%, EPS grew 106.3%, free cash flow grew 37.6% and total debt was flat, each against the same quarter a year earlier.
Follow NVST
Envista Holdings Corporation (NVST) P/E ratio
As of 16 October 2026, Envista Holdings Corporation (NVST) trades at a P/E ratio of 38.8×. Over the past ten years it has ranged from 0.0× (June 2025) to 249× (December 2025); the current reading is higher than 71% of that period. That is above the Medical Instruments & Supplies industry median of 33.8× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 77.5× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 22.8× | 7.23% |
| FY2021 | 21.3× | (87.40%) |
| FY2020 | 169× | 814.43% |
| FY2019 | 18.4× | 233.89% |
| FY2018 | 5.5× | 0.00% |
| FY2017 | 5.5× | 0.00% |
| FY2016 | 5.5× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 44.7× | (26.06%) |
| Mar 2026 | 60.4× | (22.09%) |
| Dec 2025 | 77.5× | (65.74%) |
| Sep 2025 | 226× | 270.66% |
| 27 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PLSE Pulse Biosciences, Inc compare | n/m |
| BLCO Bausch + Lomb Corporation compare | n/m |
| TFX Teleflex Incorporated compare | n/m |
| STVN Stevanato Group S.p.A. compare | 33.8× |
| MMSI Merit Medical Systems, Inc. compare | 36.4× |
| NVST Envista Holdings Corporation | 38.8× |
| ICUI ICU Medical, Inc. compare | 136× |
| ATRC AtriCure, Inc. compare | 259× |
| WRBY Warby Parker Inc. compare | 334× |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)